1. A pharmaceutical composition characterized in that it comprises an activated-potentiated form of antibodies to human gamma interferon, an activated-potentiated form of antibodies to CD4 receptor of T-lymphocytes and activated-potentiated form of antibodies to gistaminu.2. A pharmaceutical composition according to claim 1, characterized in that the activated-potentiated form of antibodies to human gamma interferon, an activated-potentiated form of antibodies to CD4 receptor of T-lymphocytes and activated-potentiated form of antibodies to histamine used in the form of activated-potentiated aqueous or aqueous -spirtovogo solution whose activity is due to process multiple serial dilution in an aqueous or aqueous-alcoholic solvent in combination with an external mechanical action-adt yahivaniem each razvedeniya.3. A pharmaceutical composition according to claim 1, characterized in that the pharmaceutical composition is in solid dosage form and comprises an effective amount of saturated aqueous or aqueous-alcoholic solution of the activated-potentiated form of antibodies to human gamma interferon, the activated-potentiated form of antibodies to CD4 receptor of T lymphocytes and activated-potentiated forms of antibodies to histamine granules neutral pharmaceutically acceptable carriers dobavki.4. A pharmaceutical composition according to claim 1, characterized in that the aqueous or aqueous-alcoholic solutions of the activated-potentiated forms of antibodies to human gamma interferon, to the CD4 receptor of T-lymphocytes and histamine are obtained by multiple successive dilution in combination with a1. Фармацевтическая композиция, характеризующаяся тем, что содержит активированную-потенцированную форму антител к гамма-интерферону человека, активированную-потенцированную форму антител к CD4 рецептору Т-лимфоцитов и активированную-потенцированную форму антител к гистамину.2. Фармацевтическая композиция по п.1, отличающаяся тем, что активированную-потенцированную форму ант
